Skip to menu Skip to content Skip to footer

2016

Journal Article

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

Paiva, Jose-Artur, Pereira, Jose Manuel, Tabah, Alexis, Mikstacki, Adam, de Carvalho, Frederico Bruzzi, Koulenti, Despoina, Ruckly, Stephane, Cakar, Nahit, Misset, Benoit, Dimopoulos, George, Antonelli, Massimo, Rello, Jordi, Ma, Xiaochun, Tamowicz, Barbara and Timsit, Jean-Francois (2016). Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study. Critical Care, 20 (1) 53, 53. doi: 10.1186/s13054-016-1229-1

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study

2016

Journal Article

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

Abdul-Aziz, Mohd H., Lipman, Jeffrey, Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Dimopoulos, George, Dulhunty, Joel, Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C., Roberts, Jason A., Paul, Sanjoy, Ribas, Antonio Margarit, De Crop, Luc, Spapen, Herbert, Wauters, Joost, Dugernier, Thierry, Jorens, Philippe, Dapper, Ilse, De Backer, Daniel, Taccone, Fabio S., Ruano, Laura, Afonso, Elsa, Alvarez-Lerma, Francisco ... Ozveren, Arife (2016). Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort. Journal of Antimicrobial Chemotherapy, 71 (1), 196-207. doi: 10.1093/jac/dkv288

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

2015

Journal Article

Population pharmacokinetics of fosfomycin in critically ill patients

Parker, Suzanne L., Frantzeskaki, Frantzeska, Wallis, Steven C., Diakaki, Chryssa, Giamarellou, Helen, Koulenti, Despoina, Karaiskos, Ilias, Lipman, Jeffrey, Dimopoulos, George and Roberts, Jason A. (2015). Population pharmacokinetics of fosfomycin in critically ill patients. Antimicrobial Agents and Chemotherapy, 59 (10), 6471-6476. doi: 10.1128/AAC.01321-15

Population pharmacokinetics of fosfomycin in critically ill patients

2015

Journal Article

COPD patients with ventilator-associated pneumonia: implications for management

Koulenti, D., Blot, S., Dulhunty, J.M., Papazian, L., Martin-Loeches, I., Dimopoulos G., Brun-Buisson C., Nauwynck M., Putensen C., Sole-Violan J., Armaganidis A., Rello J. and The Eu-Vap/Cap Study Group (2015). COPD patients with ventilator-associated pneumonia: implications for management. European Journal of Clinical Microbiology and Infectious Diseases, 34 (12), 2403-2411. doi: 10.1007/s10096-015-2495-6

COPD patients with ventilator-associated pneumonia: implications for management

2015

Journal Article

The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study)

Rhodes, Andrew, Phillips, Gary, Beale, Richard, Cecconi, Maurizio, Chiche, Jean Daniel, de Backer, Daniel, Divatia, Jigeeshu, Du, Bin, Evans, Laura, Ferrer, Ricard, Girardis, Massimo, Koulenti, Despoina, Machado, Flavia, Simpson, Steven Q., Tan, Cheng Cheng, Wittebole, Xavier and Levy, Mitchell (2015). The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study). Intensive Care Medicine, 41 (9), 1620-1628. doi: 10.1007/s00134-015-3906-y

The surviving sepsis campaign bundles and outcome: results from the international multicentre prevalence study on sepsis (the IMPreSS study)

2015

Journal Article

Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

De Waele, J. J., Lipman, J., Akova, M., Bassetti, M. , Dimopoulos, G., Kaukonen, M., Koulenti, D., Martin, C., Montravers, P. , Rello, J. , Rhodes, A. , Udy, A. A. , Starr, T. , Wallis, S. C. and Roberts, J. A. (2015). Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients. Intensive Care Medicine, 41 (5), 969-969. doi: 10.1007/s00134-015-3772-7

Erratum to: Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients

2015

Journal Article

Angiopoietin-2 associations with the underlying infection and sepsis severity

Lymperopoulou, Korina, Velissaris, Dimitrios, Kostaki, Antigone, Antypa, Elli, Georgiadou, Sara, Tsanganos, Thomas, Koulenti, Despoina , Paggalou, Evgenia, Damoraki, Georgia, Karagiannidis, Napoleon and Orfanos, Stylianos E. (2015). Angiopoietin-2 associations with the underlying infection and sepsis severity. Cytokine, 73 (1), 163-168. doi: 10.1016/j.cyto.2015.01.022

Angiopoietin-2 associations with the underlying infection and sepsis severity

2015

Journal Article

Bloodstream infections in ICU with increased resistance: epidemiology and outcomes

Dimopoulos, G., Koulenti, D., Tabah, A., Poulakou, G., Vesin, A., Arvaniti, K., Lathyris, D., Matthaiou, D. K., Armaganidis, A. and Timsit, J. F. (2015). Bloodstream infections in ICU with increased resistance: epidemiology and outcomes. Minerva Anestesiologica, 81 (4), 405-418.

Bloodstream infections in ICU with increased resistance: epidemiology and outcomes

2015

Journal Article

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study

Sinnollareddy, Mahipal G., Roberts, Jason A., Lipman, Jeffrey, Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C. and Dimopoulos, George (2015). Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study. Critical Care, 19 (33) 33, 1-7. doi: 10.1186/s13054-015-0758-3

Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study

2015

Journal Article

Point prevalence of surgical checklist use in Europe: Relationship with hospital mortality

Jammer, I, Ahmad, T, Aldecoa, C, Koulenti, D, Goranovic, T, Grigoras, I, Mazul-Sunko, B, Matos, R, Moreno, R, Sigurdsson, G. H, Toft, P, Walder, B, Rhodes, A and Pearse, R. M (2015). Point prevalence of surgical checklist use in Europe: Relationship with hospital mortality. British Journal of Anaesthesia, 114 (5), 801-807. doi: 10.1093/bja/aeu460

Point prevalence of surgical checklist use in Europe: Relationship with hospital mortality

2015

Journal Article

World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance

Carlet, Jean, Aaron, Laurent, Abassi, Mohamed Salah, Abbo, Lilian, Aboderin, Oladipo, Abraham, Edward, Abroug, Fekri, Acar, Jacques, Achour, Wafa, Adachi, Javier, Al-Abri, Seif, Al-Mousa, Haifaa, Albaya-Moreno, Antonio, Alberti, Corinne, Alfandari, Serge, Alnimr, Amani, Aranda, Celia Alpuche, de Lerma, Francisco Alvarez, Amer, Fatma, Andremont, Antoine, Angoulvant, François, Anguill, Maryvonne, Antonelli, Massimo, Antoniadou, Eleni, Arlet, Guillaume, Armaganidis, Apostolos, Arnera, Anne, Artigas, Antonio, Attali, Claude ... Zubareva, Nadezhda (2015). World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance. Medicina Intensiva, 39 (1), 34-39. doi: 10.1016/j.medin.2014.10.004

World alliance against antibiotic resistance: The WAAAR declaration against antibiotic resistance

2014

Journal Article

Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

Hanberger, Hakan, Antonelli, Massimo, Holmbom, Martin, Lipman, Jeffrey, Pickkers, Peter, Leone, Marc, Rello, Jordi, Sakr, Yasser, Walther, Sten M., Vanhems, Philippe, Vincent, Jean-Louis, for the EPIC II Group of Investigators and Koulenti, D. (2014). Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels. BMC Infectious Diseases, 14 (513) 513. doi: 10.1186/1471-2334-14-513

Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

2014

Journal Article

Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes: reply to Rhodes et al

Roberts, Jason A., Paul, Sanjoy K., Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Dimopoulos, George, Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C. and Lipman, Jeffrey (2014). Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes: reply to Rhodes et al. Clinical Infectious Diseases, 59 (6), 907-908. doi: 10.1093/cid/ciu403

Impact of loading doses on the time to adequate predicted beta-lactam concentrations in prolonged and continuous infusion dosing schemes: reply to Rhodes et al

2014

Journal Article

Respiratory infections in patients undergoing mechanical ventilation

Rello, Jordi, Lisboa, Thiago and Koulenti, Despoina (2014). Respiratory infections in patients undergoing mechanical ventilation. The Lancet Respiratory Medicine, 2 (9), 764-774. doi: 10.1016/S2213-2600(14)70171-7

Respiratory infections in patients undergoing mechanical ventilation

2014

Journal Article

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study

Blot, Stijn, Koulenti, Despoina, Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Dimopoulos, George, Kaukonen, Kirsi-Maija, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C., Lipman, Jeffrey and Roberts, Jason A. (2014). Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study. Critical Care, 18 (3) R99, 1-11. doi: 10.1186/cc13874

Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI study

2014

Journal Article

What's new in invasive pulmonary aspergillosis in the critically ill

Koulenti, Despoina, Vogelaers, Dirk and Blot, Stijn (2014). What's new in invasive pulmonary aspergillosis in the critically ill. Intensive Care Medicine, 40 (5), 723-726. doi: 10.1007/s00134-014-3254-3

What's new in invasive pulmonary aspergillosis in the critically ill

2014

Journal Article

DALI: defining antibiotic levels in intensive care unit patients. Are current beta-lactam antibiotic doses sufficient for critically ill patients?

Roberts, Jason A., Paul, Sanjoy K., Akova, Murat, Bassetti, Matteo, De Waele, Jan J., Dimopoulos, George, Kaukonen, Kirsi-Maija, Koulenti, Despoina, Martin, Claude, Montravers, Philippe, Rello, Jordi, Rhodes, Andrew, Starr, Therese, Wallis, Steven C. and Lipman, Jeffrey (2014). DALI: defining antibiotic levels in intensive care unit patients. Are current beta-lactam antibiotic doses sufficient for critically ill patients?. Clinical Infectious Diseases, 58 (8), 1072-1083. doi: 10.1093/cid/ciu027

DALI: defining antibiotic levels in intensive care unit patients. Are current beta-lactam antibiotic doses sufficient for critically ill patients?

2014

Journal Article

Approach to invasive pulmonary aspergillosis in critically ill patients

Koulenti, Despoina, Garnacho-Montero, Jose and Blot, Stijn (2014). Approach to invasive pulmonary aspergillosis in critically ill patients. Current Opinion in Infectious Diseases, 27 (2), 174-183. doi: 10.1097/QCO.0000000000000043

Approach to invasive pulmonary aspergillosis in critically ill patients

2014

Journal Article

Something Behind "Age" Reply

Blot, Stijn, Koulenti, Despoina and Rello, Jordi (2014). Something Behind "Age" Reply. Critical Care Medicine, 42 (4), E314-E315. doi: 10.1097/CCM.0000000000000179

Something Behind "Age" Reply

2014

Journal Article

Persistence of colonisation with MDRO following discharge from the ICU

Lucet, Jean-Christophe, Koulenti, Despoina and Zahar, Jean-Ralph (2014). Persistence of colonisation with MDRO following discharge from the ICU. Intensive Care Medicine, 40 (4), 603-605. doi: 10.1007/s00134-014-3258-z

Persistence of colonisation with MDRO following discharge from the ICU